Regis Healthcare Limited (ASX:REG)
Australia
· Delayed Price · Currency is AUD | Market Cap | 1.98B |
| Revenue (ttm) | 1.26B |
| Net Income (ttm) | 38.03M |
| Shares Out | 302.36M |
| EPS (ttm) | 0.13 |
| PE Ratio | 52.17 |
| Forward PE | 30.88 |
| Dividend | 0.18 (2.71%) |
| Ex-Dividend Date | Mar 12, 2026 |
| Volume | 410,535 |
| Average Volume | 739,227 |
| Open | 6.59 |
| Previous Close | 6.64 |
| Day's Range | 6.50 - 6.79 |
| 52-Week Range | 5.62 - 9.40 |
| Beta | 0.82 |
| RSI | 54.90 |
| Earnings Date | May 22, 2026 |
About Regis Healthcare
Regis Healthcare Limited engages in the provision of residential aged care services in Australia. It provides aged care services, including ageing-in-place, respite care, specialist dementia care, and palliative care services through operation of aged care homes. The company also offers home care services, such as personal care, nursing, help around your home, shopping, transport, companionship, overnight sleepovers, and cooking and meal preparation. In addition, it is involved in the provision of short-term care solutions for interim assistanc... [Read more]
Financial Performance
Financial StatementsNews
ASX 200 Top Gainers Surge as Regis Healthcare Jumps 16% on Budget Optimism and Sector Rotation
SYDNEY — Australian shares posted mixed results Thursday with the benchmark S&P/ASX 200 index closing down 0.57%, yet a handful of standout performers bucked the broader weakness, delivering double-di...
Regis Healthcare Shares Soar 16% on Australian Budget Aged Care Funding Boost
SYDNEY — Shares in Regis Healthcare Ltd surged more than 16% on Thursday as investors cheered a major federal budget announcement that promises significant changes to aged care funding, providing fres...
Healthcare co-founder offloads Toorak mansion in ‘stagnant’ market
Regis Healthcare co-founder Bryan Dorman has sold his grand Toorak home as buyers drag heals on big property deals.
Regis Healthcare Ltd (ASX:REG) (H1 2026) Earnings Call Highlights: Strong Revenue Growth Amidst ...
Regis Healthcare Ltd (ASX:REG) (H1 2026) Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures
Half Year 2026 Regis Healthcare Ltd Earnings Call Transcript
Half Year 2026 Regis Healthcare Ltd Earnings Call Transcript
Regis Healthcare Earnings Call Transcript: H1 2026
H1 FY2026 saw 18% revenue growth and 4% higher underlying EBITDA, driven by acquisitions and room price increases. Strong cash flow and RAD inflows support ongoing expansion, with margin pressure from funding changes expected to ease as reforms and operational efficiencies take effect.
Bain’s Estia Health hires banks for $700m-plus IPO; preps under way
Fund managers will be asked to compare Estia Health with listed peer Regis Healthcare, capitalised at around $2 billion on the ASX.
Regis Healthcare Transcript: AGM 2025
Strong FY 2025 financial results and increased dividends were reported, with a clear growth strategy targeting 10,000 beds by FY 2028 through acquisitions and developments. Key governance, funding, and sector challenges were discussed, and all resolutions were put to poll.
Regis Healthcare Ltd (ASX:REG) Full Year 2025 Earnings Call Highlights: Strong Financial ...
Regis Healthcare Ltd (ASX:REG) Full Year 2025 Earnings Call Highlights: Strong Financial Performance and Strategic Expansion
Full Year 2025 Regis Healthcare Ltd Earnings Call Transcript
Full Year 2025 Regis Healthcare Ltd Earnings Call Transcript
Regis Healthcare Earnings Call Transcript: H2 2025
Strong financial performance with revenue up 15%, EBITDA up 17%, and NPAT up 37% year-over-year, driven by high occupancy, acquisitions, and government funding. Strategic growth continues via acquisitions and greenfield developments, with a focus on operational excellence and meeting new regulatory standards.
Why this boss negotiated a 25pc pay rise for her staff
Regis Healthcare CEO Linda Mellors says the business is bouncing back after being hammered by the pandemic and a royal commission.
Jarden launches $133m Regis Healthcare co-founder block trade
Dorman and co-founder Ian Roberts floated Regis in 2014, retaining 27 per cent each, and have waited nearly a decade to start selling.
Regis Healthcare co-founder taps Jarden for $108m selldown
Bryan Dorman would be congratulating himself that he did not cave in to a $1.85-a-share tilt from Soul Patts back in 2020.
Regis Healthcare Ltd (ASX:REG) (H1 2025) Earnings Call Highlights: Robust Growth and Strategic ...
Regis Healthcare Ltd (ASX:REG) (H1 2025) Earnings Call Highlights: Robust Growth and Strategic Expansion
Half Year 2025 Regis Healthcare Ltd Earnings Call Transcript
Half Year 2025 Regis Healthcare Ltd Earnings Call Transcript
Regis Healthcare Earnings Call Transcript: H1 2025
Strong half-year results with 18% revenue growth, 31% higher EBITDA, and 301% net profit increase, driven by higher occupancy, government funding, and acquisitions. Strategic investments in workforce, technology, and development support continued growth and high occupancy expectations.
Regis Healthcare Transcript: AGM 2024
The meeting highlighted strong FY2024 financial results, robust occupancy, and a 96% share price increase. Strategic growth through acquisitions and new developments was emphasized, alongside sector reforms and workforce challenges. All resolutions passed with strong shareholder support.
Regis Healthcare Ltd (ASX:REG) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and ...
Regis Healthcare Ltd (ASX:REG) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and Strong Occupancy Rates
Regis Healthcare Earnings Call Transcript: H2 2024
Record revenue and EBITDA growth driven by higher occupancy, government funding, and the CPSM acquisition. Strong cash flow and a robust balance sheet support ongoing expansion, with tight supply-demand dynamics expected to persist and further CapEx planned for FY 2025.